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ABSTRACT
We report anunderdiagnosed fatal case of melioidosis that involved dygestion 
system which complicated with pneumonia, and sepsis. The case was initially 
diagnosed as acute appendicitis, and subsequently the patient underwent 
an exploratory laparatomy and appendectomy. He was discharged afer 3 
days of hospitalization. Thirty days afterward, he was admitted to another 
private hospital to experience another exploratory laparatomy with indication 
of pancreatitis, intra-abdominal organs adhesions, and postoperative 
enterocutaneous fistula (ECF), and hospitalized there for 25 days. He eventually 
suffered from sepsis, pneumonia, unclosed ECF, anemia, hypoalbuminemia, 
and electrolyte imbalance. He then referred to a tertiary teaching hospital and 
hospitalized there for a total 134 days until he passed away. His clinical condition 
was declining, despite a long course of broad spectrum antibiotics. Treatment 
delay, prolong hospitalization, and complications were the inevitable, although 
Burkholderia pseudomallei was finally identified 2 weeks prior to his death. 
This case highlight that melioidosis canassociate with acute appendicitis, and 
that the delay on its diagnosis and treatment may trigger complications and 
death. 
ABSTRAK
Kami melaporkan kasus fatal melioidosis yang melibatkan sistem pencernaan 
dengan komplikasi pneumonia, sepsis, dan berakibat pada kematian. 
Appendicitis akut adalah diagnosis klinis awal pada kasus melioidosis ini, dan 
pasien langsung menjalani operasi laparatomi eksplorasi dan appendectomy, 
kemudian pulang setelah mondok selama 3 hari di sebuah rumah sakit swasta. 
Tiga puluh hari setelahnya, pasien mondok di rumah sakit swasta lainnya 
selama 25 hari, dan menjalani operasi laparatomi eksplorasi yang ke dua 
dengan indikasi pankreatitis, perlengketan organ intra abdomen, dan fistula 
enterokutan. Kondisi klinis pasien memburuk, dan terjadi sepsis disertai 
penumonia, luka fistula entero-kutan (FEK) terbuka, anemia, hypoalbuminenia, 
dan ketidakseimbangan elektrolit. Kemudian pasien dirujuk ke rumah sakit 
pusat rujukan dan pendidikan dan mondok selama 134 hari sebelum akhirnya 
meninggal. Kondisi klinis pasien terus memburuk meskipun telah mendapat 
rangkaian terapi antibiotik berspektrum luas. Keterlambatan terapi, lamanya 
waktu pemondokan, dan terjadinya komplikasi menjadi tidak terelakkan, 
meskipun B. pseudomallei dapat diidentifikasi pada 2 minggu sebelum 
kematian. Kasus ini menekankan pentingnya memahami bahwa presentasi 
melioidosis secara klinis dapat berhubungan dengan appendicitis akut, dan 
keterlambatan dalam mendiagnosis dan terapi dapat memicu terjadinya 
komplikasi dan kematian. 
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INTRODUCTION
Melioidosis is an infectious disease 
caused by Burkholderia pseudomallei.1 
Clinical feature of melioidosis vary, 
with major presentation as sepsis, but 
specific clinical feature and severity 
depending on the bacterial entry route 
into host, host immune response, 
bacterial strain and load.1 Case fatality 
rate of melioidosis range from 10% 
to 50%, with risk of having recurrent 
infection is 5-28% in patients who 
survived acute melioidosis.1Burkholderia 
pseudomallei infamous with its 
diverse antimicrobial resistance 
feature, including resistant to third-
generation cephalosporins, penicillins, 
rifamycins, and aminoglycosides.2 
They also showed relative resistance 
to quinolones and macrolides which 
limits therapeutic options.2 However, 
most of B. pseudomallei show consistent 
susceptibility to meropenem and 
ceftazidim that experts and US CDC 
considered intravenous meropenem 
and ceftazidim as effective therapy for 
melioidosis.3,4
In Indonesia, melioidosis was 
scarcely reported although some 
studies predicted that Indonesia was 
one of endemic countries in Southeast 
Asia.5,6 We describeda fatal melioidosis 
that occurred in 2015. This case report 
elucidatedthat melioidosis was rarely 
accurately and timely diagnosed as 
its clinical presentation might similar 
or associated with other infectious 
diaseases, particularly in limited setting 
like Indonesia. In this case, melioidosis 
was associated with acute appendicitis 
and pancreatitis. In addition, multiple 
attempts of major operation without a 
timely identification of the etiology, and 
long term of empirical broad spectrum 
antibiotics treatment showed a very 
limited benefit for the patient. This 
case report highlight the importance 
of early diagnoses establishment, and 
appropriate antibiotic management in 
melioidosis.
CASE REPORT
A 31 years old male suffered from 
a chronic post surgical wound, after an 
appendectomy in a private hospital in 
May 2015. Two weeks after discharged, 
he complained of abdominal pain, 
and fever as infection inflicted on the 
unhealed surgical wound. He went 
to another private hospital, where 
abdominal multi-slice computed 
tomography (MSCT) scan was conducted 
and revealed a massive gut adhesion and 
excessive pus surrounding his pancreas. 
He then was admitted for exploratory 
laparotomy. However, 25 days after his 
second operation, an apparent sepsis 
finally directed his physician to refer him 
to Dr. Sardjito General Hospital, a tertiary 
and teaching hospital in Yogyakarta. He 
was admitted into Emergency 
In the emergency department, he 
appeared skinny (body weight 55 kg, 
body mass index: 19.03) and weak, with 
fever (38.6 °C), tenderness, shortness 
of breath (respiratory rate: 26 cycles/
min), elevated heart rate (148 beat/min), 
and blood pressure of 107/60 mmHg. 
The patient chief complain waspain. 
Pus was continuously dripped from 
his wound. Laboratory examination 
supported diagnoses of infection with 
leucocytosis and neutrophilia (TABLE 1). 
On physical examination, the attending 
physicians found consolidation in both 
side of his lung. A thoracic rontgen 
photograph showed a prominent right 
-bilateral pleural effusion (FIGURE 2A). 
The physicians established diagnosis 
and management of imminent septic 
shock complicated with bilateral 
pneumonia and pleural effusion, 
anemia, hypoalbuminemia, and surgical 
site infection of entero-cutaneous fistula 
(ECF). Resuscitation was conducted in the 
Emergency Department, and antibiotics 
(ceftriaxone and metronidazole) were 
administered in a combination.
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Week 5 of May 2015 Acute appendicitis Symptoms of abdominal pain  and fever was fisrt recognised. General condition was stable.  At the discharge, he was conscious despite the unhealed post operational wound. 
Exploration Laparatomy with 
Appendictomy. Detail of antibiotic treatment was unknown. Discharge after 3 days of hospitalization in a private hospital June 8-22th,  2015 Fever, chills, constant abdominal pain, and an open post-operational wound. General condition was weak. Diagnoses in this hospital was unknown 
Treatment was unknown Reffered to another private hospital Discharge after 3 days of hospitalization 
 at Private Hospital “A” 
at Private Hospital “B” 
at Private Hospital “C” June 22th-July 16th,  2015 His family was told by the physician that the pancreas was totally damaged.During his 25 days hospitalization, his wound was not dissipited, rather it developed into a 
entero-cutaneous fistulae (ECF).  
MSCT Abdomen: free fluid around his pancreas, suggested a pancreatitis 
Exploration Laparatomy Discharge plan: continue with homecare Diagnoses in this hospital was unknown 
July 16-21th,  2015 at Home Continuous abdominal tenderness, he was unconscious at July 21th, 2015 Homecare: daily wound dressing  
July 21th,  2015 at  tertiary teaching hospital Admission to emergency room (ER) at 10:30 am. His chief compalin was fever with shortness of breath, and abdominal pain, particularly in the wound On examination: Rhonchi heard during auscultation in both of his lung. ECF was wet with dripping pus, and fever presented. Bowel sounds was presented, tenderness was positive, although abdominal wall was supple. 
Chest X ray: bilateral lung consolidation, particularly in the lower part of right lung 
Life saving 
management. Integrative treatment Antibiotics.Albumin, and red blood cell transfusion.Blood culture 
Post exploration laparatomy, post appenditomy with ECF, acute pancreatitis,  anemia, hypoalbuminemia, hyponatremia, pneumonia, and sepsis. 
July 25th,  2015 a respiratory failure occurred, ARDS, septic shock 
ICU: ventilator support. Hemodynamic stabilization. Antibiotics 
July 28th-Nov 23th,  2015  
Primary Metabolic Alkalosis, with secondary Respiratory Acidosis. Fever, and tenderness was persistent. ECF was unhealed. He was unconscious 
Fever, and tenderness was persistent. ECF was unhealed.  Transfer to ward, Nasal canule Oxygen. Antibiotics 
Primary Respiratory Acidosis, Chronic, with: Secondary Metabolic Acidosis and Additional Metabolic Alkalosis. ECF was unhealed. Steady high fever. He was unconscious 
Nov 23th- Dec 1st,  2015 ICU: ventilator support. Hemodynamic stabilization Antibiotics ARDS, septic shock Dec 2nd,  2015 His condition rapidly declining, he died on Dec 2nd, 2015 
Died 
Clinical sign and symptom Diagnoses Treatment and management 
FIGURE 1. A timeline of disease progress, intervention, and outcome of melioidosis.
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TABLE 1. Laboratory tests of the melioidosis case  during the hospitalization.
Test July 21th, 2015 July 26th, 2015 
(ICU)
Nov 28th, 2015 
(ICU)
Dec1st, 2015 
(ICU)
Hemoglobine (g/dL) 7.2 7.6 10.4 8.8
Hematocrite (%) 22.9 24.3 32.3 27.9
Leucocyte (/μL) 27,000 19,670 35,160 47,800
Neutrophil (%) 84.4 87 88.7 90.7
Lymphocyte (%) 7.1 6 5.1 4.8
Monocyte (%) 8.4 6.7 3.9 3.7
Basophil (%) 0.1 0.1 0.2 0
Eosinophil (%) 0 0.2 2.1 0.8
Thrombocyte (/μL) 415,000 447,000 281,000 158,000
PH 7.442 7.299 7.295
PO2(mmHg) 105.7 112.3 101,1
PCO2(mmHg) 46.6 51.7 53
SO2(%) 99.6 97.6 96.5
cHCO3(mmol/L) 29.2 24.8 25.2
BE (mmol/L) 6 -1.9 -1.6
BEecf (mmol/L) 7 -1.6 -1.3
AaDO2 484.8 0 336.6
a/AO2 17.9 100 23.1
FiO2(%) 0.9 0.21 0.7
Temperature (°C) 38.7 38.3 36.9 37
Albumin (g/L) 1.68 1.65 1.84
Natrium (mmol/L) 131 133 154 153
Chloride (mmol/L) 99 94 114 114
Kalium (mmol/L) 4.3 3.42 3.8 2.9
Amilase 121
Lipase 180
After five days of hospitalization, his 
condition was worsening.  Fever and lung 
consolidation were persisted although 
broad-spectrum antibiotics have been 
administered,  and transfusion of albumin 
and blood, as well as resuscitation had 
been conducted. On July 25th, 2015 he 
was transferred into inensive care unit 
(ICU), as he fell to septic shock. During 
the 3 days of intensive care, a regimen 
of antibiotics comprised metronidazole, 
meropenem, and aztreonam, as well 
as ventilator support were administed. 
The patient was transferred back 
to the ward as his condition was 
stable on July 27th, 2015. However the 
following4 months of hospitalization 
were a prolong fluctuation of  clinical 
condition, which was repeat signs of a 
temporary stable,pre-shock conditions.
The ECF was never healed, and the 
clinical manifestation was exaggerated 
with pneumonia, electrolyte imbalance, 
alkalosis, acidocis, and persistent sign 
of sepsis, tachypnea, tachycardia, 
leucocytosis, neutrophilia, lymphopenia, 
and anemia (TABLE 1). 
An abdominal MSCT was conducted 
at August 7th, 2015 suggested a damaged 
pancreas, with numerous of small size 
intra-abdominal granuomas (FIGURE 
2B). Amylase and lipase were elevated 
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supported the diagnosis of pancreatitis 
(TABLE 1), combined with leucocytosis 
and neutrophilia the suspected etiology 
was bacterial infection. During the 
135 days of hospitalization,nine sets 
of two sides blood cultures were taken 
at different days, and the tests were 
performed with Vitec2, however none 
of it yielded positive result (TABLE 2). 
Pus, urine and sputum cultures were 
also conducted, however it failed to 
reveal the etiology, until the last wound 
culture was conducted at day 118 of his 
hospitalization at another laboratory 
of microbiology, which revealed B. 
pseudomallei among others bacteria 
cultivated from the same wound culture 
(TABLE 2). 
B
ii
ii
FIGURE 2. Chest X-Ray and abdominal MSCT of the melioidosis. (A). Bilateral lung 
consolidation was observed from the chest X-ray. (B). MSCT of the abdomen 
at level of splenic artey (i) and pancreas tail. MSCT showed signs of intra-
abdominal adhesion, small granulomas (ii).
A B ii ii 
 
Antibiotics regimen, steroid, 
and antipyretic were continuously 
changing empirically, following 
the patient’s response during 
hospitalization.  In August 2015, he 
receive antibiotics combination of 
gentamycin, metronidazole, ceftazidime, 
levofloxacin, and amikacin, as swell as 
antifungal fluconazole. The next month, 
September, the course of antibiotics 
were amikacin, imipenem, cefixime, and 
imipenem-cilastatin, with antifungal of 
fluconazole. In October 2015, imipenem-
cilastatin, levofloxacin, amikacin, and 
colistin were implemented replaced 
the previous regimen. In November 
2015, the antibiotics regimen comprised 
imipenem-cilastatin, levofloxacin, 
cefotaxime, amikacin, ceftazidime, 
aztreonam, and meropenem. However 
the clinical condition plunged into septic 
shock, and at November 24th, 2015 the 
patient was again transferred to ICU, 
where he receive intensive care for 8 
days before finally he passed away at 
December 2nd, 2015.
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TABLE 2. Culture of blood, pus, urine, sputum, and wound swabs during the 
135 days of hospitalization at tertiary teaching hospital.
Date Material Result
Jul 23rd, 2015 Blood (2 sites) Negative
Jul 27th, 2015 Blood  (2 sites) Negative
Aug 3rd, 2015 Pus Negative
Aug 12th,2015 Pus Escherichia coli, ESBL + (contamination?)
Aug 12th, 2015 Blood  (2 sites) Negative
Aug 16th, 2015 Blood  (2 sites) Negative
Aug 24th, 2015 Blood  (2 sites) Negative
Aug 25th, 2015 Urine Negative
Aug 29th, 2015 Sputum Streptococci
Oct 12th, 2015 Blood (2 sites) Negative
Oct 27th, 2015 Blood (2 sites) Negative
Nov 3rd, 2015 Pus Negative
Nov 11th, 2015 Blood (1 sites) Negative
Nov 15th, 2015 Blood (2 sites) Negative
Nov 20th, 2015 Wound swab 1. Enterobacter cloacae
2. Klebsiella oxytoca
3. Pseudomonas putida
4. B. pseudomallei , with susceptibility 
pattern:
•	 susceptible to: amikacin, meropenem
•	 resistant to: amoxycillin, clavulanate, 
ampicillin, eritromycin, gentamycin, 
levofloxacine, chloramphenicol, 
penicillin, cefepime, cefixime, 
ceftriaxone, cefuroxime, 
ciprofloxacine, and sulfamethoxazole
The research conducted on 
melioidosis was approved by the 
Medical and Health Research Ethics 
Committee, Faculty of Medicine-Public 
Health and Nursing, Universitas Gadjah 
Mada, Yogyakarta (Ref.No. KE/FK/1346/
EC/2019). Informed consent was obtained 
from the next of kin. 
DISCUSSION
Melioidosis is a severe infectious 
disease with diverse clinical 
manifestations and can be difficult to 
diagnose as it requires microbiologic 
expertise to examine the suspected case.7 
Burkholderiapseudomallei is the causative 
agent, a gram negative bacteria which 
able to survive  in  both  intracellular 
and extracellular for decades in hosts, 
and endemic to tropical regions of Asia, 
South America, Central America, Pacific 
countries, and Indian ocean islands and 
some African countries.7 Burkholderia 
pseudomalleiare dubbed as tropical time 
bomb or Vietnamese bomb, as they can 
cause a latent infection with the longest 
documented interval between exposure 
and clinical manifestation is 62 years.8 
They are tier 1 select agent by the US 
government, and the culture required 
special precaution to reduce exposure 
risk.7,8  There  is  no  pathognomonic 
clinical feature of melioidosis.7 The 
current standard diagnostic is culture, 
however the colony of  B. pseudomallei 
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can be miss-identified as culture 
contaminant or other species, especially 
by laboratory staff who unfamiliar 
with this organism.7 Burkholderia 
pseudomallei colonies are usually 
non-lactose fermenter with metallic 
sheen and become pink and become 
umbonated or rugose on Mac Conkey 
agar after 48 hours.7 Under microscope 
with gram staining, the bacteria appear 
as bipolar or “safety pin” shaped.7 
However if the specimen obtained 
from patients received antibiotics 
before, the appearance rarely seen, 
instead  B. pseudomallei may appear 
highly atypical resembling yeasts or 
filamentous.7 The one or two days age of 
colonies usually erroneously dismissed 
as contaminant or miss-identified as 
Pseudomonas spp or other organisms 
when standard diagnosticmethods are 
used.7 The performance or commercially 
systems widely used such as API 20NE 
(bioMe ́rieux, Craponne, France), 
Phoenix (Becton, Dickinson, and 
Company, Franklin Lakes, NJ, USA), and 
Vitex 2 (bioMe ́rieux, Craponne, France) 
to correctly identify B. pseudomallei 
were ranging  37-99%, 0-28%, 0-98% 
respectively.7 Moreover, currently no 
specific and sensitive serologic or rapid 
tests available to identify B. pseudomallei, 
although experienced laboratory 
staff can identify them with some 
additional antibiotic tests and specific 
media (Ashdown), or confirm them 
with PCR.7Burkholderia pseudomallei 
is typically susceptible to amoxicillin/
clavulanic acid, trimethoprim-
sulfamethoxazole,  and ceftazidime, but 
resistant to aminoglycosides, colistin 
and polymyxin.4,7
Clinical features of melioidosis vary, 
comprises acute, chronic, and latent 
diseases. Acute clinical manifestations 
of melioidosis vary widely, including 
sepsis, pneumonia, or internal organ 
abscesses with or without localized 
infection, therefore melioidosis should 
be suspected from every patients in 
endemic regions with community 
acquired sepsis or pneumonia, urinary 
tract infection, upper respiratory tract 
infection, or abscesses especially for 
those with predisposing factors such 
as diabetes mellitus, renal disease or 
immunosuppression.7 The chronic 
manifestations with symptoms usually 
occur after 2 months of exposure, and 
are often mimic other diseases such as 
tuberculosis and cancer.7 The duration 
of latent melioidosis takes decades, 
thus a complete travel history should 
be obtained accordingly.7 Relapse or 
re-infection with the same or different 
genotype of B. pseudomallei may 
occur after antibiotics treatment.8 
Combination of the aforementioned, 
the lack of clinicians and laboratory 
staff awareness, and failure to elicit 
travel history from patients returning 
from endemic area are contributed to 
the difficulties on clinical diagnosis of 
melioidosis.7
The major clinical feature of 
melioidosis in this case was sepsis, 
resulted from a prolong misdiagnoses. 
The reccurent septic shocks were 
originated from the untreated infection. 
The unhealed ECF was also a sign of 
uncontrolled infection. The existed 
comorbidities and or complication, 
such as pneumonia, anemia, 
hypoalbominemia, hiponatremia, 
andelectrolyte imbalance may contribute 
significantly to the worsening condition 
and lead to the mortality after long 
period of hospitalization.
Bacterial culture is the gold 
standard for diagnose melioidosis.7 
However, given the persistent sign 
and symptoms of infection (high 
fever although anti-pyretic already 
administered, leucocytosis, neutrophilia, 
and monocytosis), blood cultures 
were unable to identify the etiology. In 
hyperendemic areas such as Thailand, 
the positive rate of  B. pseudomallei from 
blood culture range from 9.1 to16.5% of 
suspected melioidosis cases.9-11 A seven-
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year study in Thailand analyzed 63,066 
blood cultures reported isolation of B. 
pseudomallei in 11% of 7,296 positive 
blood cultures.12
Melioidosis cases may manifest as 
systemic infection with cause patient 
fatality, but blood cultures could result 
false negative.7 Therefore specific-
monoclonal antibody assays were 
suggested to identify melioidosis, as 
several study reported high sensitivity 
and specificity (> 95%).13,14 In addition, 
rapid diagnostic tools were also 
recommended for screening in the area 
with limited resources where culture is 
unavailable.15 Molecular methods are 
certainly valuable diagnostics tools, 
which can provide high sensitivity and 
specificity, as well as rapid identification 
however the technology is scarcely 
available in developing countries.16-18
The major challenge in establishing 
diagnosis of melioidosis is the selection of 
colony from culture prior  to conducting 
further identification whether using 
biochemical or molecular methods.19,20 
Many bacterial colonies are usually 
selected after 18-24 h of incubation, 
since they have produced specific colony 
features of optimum size of colony.7,20 In 
contrast, the colony of B. pseudomallei 
after 18-24 hours of incubation, appears 
as a contaminant colony.7,20 Experienced 
laboratory technician will wait up to 3 
days to re-evaluate the colony, so that the 
colony can be identified.7,20
In this case, the problem comprised 
diagnostic challenges, complications, 
and the rapid deterioration of patient 
condition, which unresponsive to the 
antibiotics treatment. In Yogyakarta 
where melioidosis was very rarely 
reported, identification was a big 
challenge. Burkholderia pseudomallei 
was not identified in the early phase 
of the patient illness that might 
cause delay of appropriate infection 
management, which eventually might 
lead to patient death. Patient suffered 
from pneumonia, hypoalbuminemia, 
electrolyte imbalance, acute pancreatitis, 
post-operative colo-cutaneus fistula 
with secondary infection, acute kidney 
injury, melena, sepsis, and prolong 
hospitalization as the consequences 
of etiology misidentification. Prolong 
hospitalization, and immobilization 
also contributed to hospital-acquired 
pneumonia with bilateral lung effusion, 
which finally lead to acute respiratory 
distress syndrome (ARDS).
The isolated B. pseudomallei which 
susceptible to meropenem and amikacin 
only, and the presence of other pathogens 
(TABLE 3) altogether developed into 
infectious agents package which very 
difficult to combat. The physicians 
have struggled to stabilize patient 
condition, with the available resource. 
Unfortunately, antibiotic administration 
management was also challenging 
since empirical treatment in this case 
was prone to ineffective to diminish 
infection, then severe complications 
accompanied, that made infection even 
more difficult to be cured. It showed 
the dynamic of antibiotic treatment 
and the disease journey. It showed that 
patient had enduring prolong fever, 
infection that unresponsive to antibiotic 
treatment, and recurrent septic shocks 
before finally he passed away.
CONCLUSION
Lesson learned from this case is 
the crucial of diagnoses establishment 
and appropriate antibiotic treatment in 
melioidosis management. In addition, 
in the setting where resource are 
limited, a rapid diagnostic tool will help 
the clinicians to adjust the empirical 
treatment prior the culture result.
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